M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medicofarma Biotech SA
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Retained Earnings
-zł3.1m
CAGR 3-Years
-33%
CAGR 5-Years
-114%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Retained Earnings
zł2.2m
CAGR 3-Years
-35%
CAGR 5-Years
N/A
CAGR 10-Years
35%
R
Ryvu Therapeutics SA
WSE:RVU
Retained Earnings
-zł15.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Retained Earnings
zł202.8m
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Retained Earnings?
Retained Earnings
-3.1m PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Retained Earnings amounts to -3.1m PLN.

What is Medicofarma Biotech SA's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-114%

Over the last year, the Retained Earnings growth was 0%. The average annual Retained Earnings growth rates for Medicofarma Biotech SA have been -33% over the past three years , -114% over the past five years .

Back to Top